Protease Inhibitors to Treat Hepatitis C in the Swiss HIV Cohort Study: High Efficacy But Low Uptake
Background: Combination therapy with pegylated interferon, ribavirin and protease inhibitors (PI) has become the standard of care for chronic hepatitis C virus (HCV) genotype 1 infection. However, there is limited information on treatment outcomes in HIV/HCV coinfected patients in clinical routine settings. We assessed PI treatment uptake and efficacy in the Swiss HIV Cohort Study…